Actively Recruiting
Navigating Advanced Illness Goals And Treatment With Digital Engagement (NAVIGATE)
Led by National University of Singapore · Updated on 2025-09-15
200
Participants Needed
1
Research Sites
100 weeks
Total Duration
On this page
Sponsors
N
National University of Singapore
Lead Sponsor
N
National University Hospital, Singapore
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this two-armed, parallel-design, pre-/post-intervention assessment clinical trial is to learn if a digital and interactive website helps to improve advance care planning (ACP) engagement among caregivers of patients with serious illness. The main questions it aims to answer are: Does the website increase ACP engagement of caregivers of patients with serious illness? Researchers will compare the digital and interactive website to the usual care (a digital booklet) to see if the digital intervention works to improve ACP engagement among caregivers. Participants who are caregivers will: * Be introduced to a digital website and asked to explore the site over the course of the study. * Complete four self-administered questionnaires (baseline, one-week, six-week, and six-month). Participants who are patients will not have any intervention assigned and will only have their observational data collected through four interviewer-administered questionnaires (baseline, one-week, six-week, and six-month)
CONDITIONS
Official Title
Navigating Advanced Illness Goals And Treatment With Digital Engagement (NAVIGATE)
Who Can Participate
Eligibility Criteria
You may qualify if you...
1. Patient Participants
- Singapore resident aged 21years and above,
- patient able to identify one main caregiver in the care and medical decision-making for the patient;
- patient able to communicate in either English, Chinese, Malay or Tamil;
- patient meeting one of the following illness criteria: 4a. Patients with brain tumours: histological and/or radiological diagnosis of glioma or brain metastases.
4b. Patients with spontaneous intracerebral haemorrhage (SICH) based on radiological diagnosis of SICH on baseline computed-tomographic scans.
4c. Patients with CKD Stage 4 and 5, identified at G4 or G5 of CKD, glomerular filtration rate (GFR) 30 ml/min or less, inclusive of kidney failure on kidney replacement therapy; and (5) Physicians assessment that ACP is appropriate for the patient by physicians.* (*) The attending clinicians may base the assessment of ACP appropriateness on several factors in addition to high mortality risk. As a baseline, clinicians are asked to base their assessment of high mortality risk using the validated "Surprise" question.
2. Patient participants
You will not qualify if you...
- Patients unable to identify a caregiver who is a medical decision-maker,
- Patients are currently or was previously healthcare workers; or
- Patients are diagnosed with dementia or deemed cognitively impaired as determined by the Abbreviated Mental Test.
3. Caregiver Participants Inclusion Criteria:
- caregivers are identified as a medical decision-maker for the patient
- Singapore resident aged 21 years and above; and
- able to communicate in English
4. Caregiver Participants
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National University Hospital
Singapore, Singapore, 119074
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here